Offer Type
Offered
The AbC-19 Rapid Antibody Test was developed using the same antigen that the AstraZeneca vaccine is based on. To protect against SARS-CoV-2, a patients’ antibodies need to be directed against the critical spike protein part of the virus. In fact, hospitalized patients that have antibodies mainly directed towards the ‘wrong’ part of the virus (the Nucleocapsid protein) were shown to be more likely to die.